Description
Speakers:
Ivana Tašková, PharmD, PhD, PGDip
- Clinical Pharmacist, Psychiatric Hospital Bohnice, Prague, Czech Republic
- Chair, ESCP Mental Health Special Interest Group
- Researcher, Charles University, Faculty of Pharmacy, Czech Republic
Prof. Dr. Martina Hahn, PharmD, PhD
- Department of Mental Health, Varisano Hospital Frankfurt Hoechst
- University Hospital Frankfurt, Department of psychiatry, psychosomatics and psychotherapy- Goethe Universisy
- Department of pharmacology and clinical pharmacy Philipps- University Marburg
Learning objectives
By the end of the webinar, participants should be able to:
- Understand a structured, practice-oriented approach to personalised pharmacotherapy in psychiatry based on real-life clinical scenarios
- Recognise how therapeutic drug monitoring and pharmacogenetic information can inform clinical decision-making in psychiatry
- Become familiar with high-risk situations in psychiatric patients, including polypharmacy, drug–drug interactions, organ impairment, and adverse drug reactions
- Become familiar with practical resources and evidence-based tools that support safe and effective psychopharmacotherapy in clinical practice
Description
The aim of this webinar is to demonstrate how clinical pharmacists can actively contribute to personalised pharmacotherapy in psychiatry in routine clinical practice. The session will focus on a practice-oriented, case-based approach, illustrating how clinical pharmacists support complex decision-making and improve treatment safety and effectiveness.
Through real-life clinical examples, the webinar will demonstrate how personalised strategies can be applied in patients with multimorbidity, organ impairment, or adverse drug reactions. It will highlight the use of tools such as therapeutic drug monitoring and pharmacogenetic testing in clinical decision-making, as well as structured clinical approaches to optimise treatment, manage drug interactions, and support the safe use of high-risk psychotropic medications.
The session will also emphasise how clinical practice and applied research can be integrated, demonstrating how data-driven tools and clinical reasoning can support individualised care in psychiatry. Particular emphasis will be placed on practical resources and evidence-based tools relevant to psychiatric pharmacotherapy, equipping participants with strategies that can support their routine practice.
Ivana Tašková is Head of the Clinical Pharmacy Department at the Psychiatric Hospital Bohnice in Prague, Czech Republic, one of the largest psychiatric hospitals in Central Europe, where she has worked as a clinical pharmacist for over 10 years. She also leads an outpatient clinical pharmacy service. She specialises in psychopharmacology and medication optimisation in psychiatric care, with a strong focus on personalised pharmacotherapy.
She graduated from the Faculty of Pharmacy, Charles University in Hradec Králové, and holds a Postgraduate Diploma in Clinical Pharmacy from Queen’s University Belfast. She obtained her PhD from Masaryk University in Brno, focusing on drug safety.
Ivana is a researcher at Charles University and is currently involved in the NETPHARM project, which aims to advance personalised pharmacotherapy in older adults. In addition, her research focuses on personalised psychopharmacotherapy and its implementation in routine clinical practice.
She is actively involved in research, education, and guideline development, contributing to undergraduate and postgraduate clinical pharmacy education. She has authored and co-authored publications in international peer-reviewed journals and books or chapters. She previously served on the board of the Czech Society of Clinical Pharmacy and currently chairs the Mental Health Special Interest Group of the European Society of Clinical Pharmacy, where she supports collaboration and development of clinical pharmacy services in psychiatry across Europe.
Martina is Specialised in clinical pharmacy (“Fachapotheker”), with a PhD in the mental health department, and Doctor of pharmacy degree at the university of Florida. She holds a Professor position at the University of Marburg in clinical pharmacy since 2020. She is also a Clinical pharmacist in the mental health department in Frankfurt and a scientist at Goethe university. Her research interests in TDM, PGX, drug interactions and interdisciplinary collaboration.
